MyFinsight
Home
About
Contact
Back
Income Statement
BIOTRICITY INC. (BTCY)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$790,462
(88.58%↑ Y/Y)
Device Sales
$502,601
Technology Fees
$3,371,392
Net loss
attributable to common...
-$754,293
(89.14%↑ Y/Y)
Translation adjustment
-$36,169
(-253.37%↓ Y/Y)
Revenue
$3,873,993
(21.00%↑ Y/Y)
Net loss before
dividends
-$671,977
(81.81%↑ Y/Y)
Preferred stock dividends
$82,316
(-58.65%↓ Y/Y)
Gross profit
$3,116,800
(31.89%↑ Y/Y)
Cost of revenue
$757,193
(-9.70%↓ Y/Y)
Net loss before
income taxes
-$671,977
(81.81%↑ Y/Y)
Gain (loss) upon
convertible promissory...
$8,433
(106.61%↑ Y/Y)
(loss) profit from
operations
$281,945
(125.24%↑ Y/Y)
Other income
(expense) note 9
$66,671
(129.01%↑ Y/Y)
Total operating
expenses
$2,834,855
(-18.54%↓ Y/Y)
Accretion and
amortization expenses note...
-$153,572
(86.58%↑ Y/Y)
Change in fair value of
derivative liabilities...
-$25,200
(91.79%↑ Y/Y)
Interest expense
$850,254
Research and development
expenses
$696,163
(35.47%↑ Y/Y)
Selling, general and
administrative expenses
$2,138,692
(-27.90%↓ Y/Y)
Back